HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 16 filers reported holding HORIZON PHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,949,000 | +124.2% | 225,074 | +65.7% | 0.05% | +122.7% |
| Q4 2018 | $2,654,000 | +452.9% | 135,830 | +453.7% | 0.02% | +633.3% |
| Q3 2018 | $480,000 | -32.3% | 24,530 | -42.7% | 0.00% | -25.0% |
| Q2 2018 | $709,000 | -85.7% | 42,836 | -86.0% | 0.00% | -85.7% |
| Q4 2016 | $4,958,000 | +181.5% | 306,443 | +215.5% | 0.03% | +211.1% |
| Q3 2016 | $1,761,000 | +85.6% | 97,143 | +68.7% | 0.01% | +125.0% |
| Q2 2016 | $949,000 | +273.6% | 57,600 | +276.5% | 0.00% | +300.0% |
| Q1 2016 | $254,000 | -67.2% | 15,300 | -57.2% | 0.00% | -75.0% |
| Q4 2015 | $774,000 | -31.1% | 35,709 | -37.0% | 0.00% | -33.3% |
| Q3 2015 | $1,124,000 | -92.5% | 56,700 | -86.9% | 0.01% | -92.2% |
| Q2 2015 | $15,050,000 | +128.5% | 433,233 | -15.2% | 0.08% | +97.4% |
| Q4 2014 | $6,587,000 | +1798.3% | 511,000 | +1709.7% | 0.04% | +1850.0% |
| Q3 2014 | $347,000 | – | 28,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |